HRSA OPAIS is a registration database. It records who is enrolled in 340B and which contract pharmacies they have registered. It carries no purchase volume, no revenue, no 340B savings and no claims. So no dollar figure anywhere on this dashboard is attributed to it, and none appears in the entity table, in the four headline counts, or as a property of any entity.
Dollars appear in exactly two places, both in section 03. Inside the scenario model, where both inputs are yours and are labelled as your assumptions. And in the three market anchors, where each figure carries its own source that is not OPAIS. The build fails its own QA if a dollar figure turns up anywhere else.
Everything else on screen is a count, a date, or a score computed from counts and dates. Every entity name, address, official, phone and NPI is read verbatim from a source file. The two scores are PRISM's opinion, and both are shown as full arithmetic inside every row.
Four numbers, each recounted straight from the source export. Terminated and non-participating entities are excluded from every one of them, and from every view below.
The rest of this dashboard is evidence. This section is the argument.
These are active Health Center Program sites. Every one of them is already enrolled in 340B and already eligible today. Not one of them holds a single active contract pharmacy arrangement.
There is no incumbent to displace. There is no contract to unwind. There is no chain relationship to break. The work is a build, not a takeaway.
That is 54.8% of the 14,185 participating Health Center Program sites in the national file. It is a count of rows, not a model.
Work the list in four bands. The Build score sorts them and the arithmetic is printed inside every row.
Inside a band, sort by the contract pharmacy gap: sites divided by active contract pharmacies. The wider the gap, the more sites are sitting uncovered right now.
This is the sharpest point available, and most of the industry has it backwards.
Of the 38 manufacturers on the NACHC contract pharmacy restriction chart, 31 do not cap contract pharmacies for a covered entity that operates its own in-house pharmacy. Only 7 cap regardless of an in-house pharmacy: Amgen, Johnson & Johnson, Liquidia, Mitsubishi, Novo Nordisk, Organon and Sandoz.
RiteChoice builds in-house pharmacies. So the thing the market treats as the biggest threat to 340B is, for this service, structurally an argument in its favor. The restriction regime is the reason to build, not a reason to wait.
Source. NACHC manufacturer contract pharmacy restriction chart, dated 2026-04-20. That chart is not part of the HRSA file behind this dashboard and no restriction status is claimed for any individual entity in the table.
The rheumatology partner angle runs on the identical data. Pennsylvania only, built as lens 03.
0 participating Pennsylvania sites sit in one of 0 counties that hold no rheumatologist at all, and they already carry a 340B pharmacy channel. Those sites need a specialist. A virtual rheumatology partner needs a dispensing channel. The list is already built.
This is a secondary motion. It does not compete with the build motion for the same call, and it is scoped to Pennsylvania because the rheumatology counting is Pennsylvania only.
This is the only place on this dashboard where dollars are allowed, and both scenario inputs belong to the reader. Nothing below is a PRISM forecast and nothing below comes from HRSA. Move the two inputs and the arithmetic recomputes on screen.
Both values are reader inputs. PRISM is not asserting either one. Change them to whatever you believe and read the result.
This is multiplication, not a forecast. It carries no ramp, no churn, no cost to serve and no time to first revenue.
These three figures carry their own sources and are not properties of any entity in the table below. HRSA OPAIS remains a registration database. It contains no purchase volume, no revenue, no savings and no claims, and no dollar figure anywhere on this page is attributed to it.
One file, two buyers, three ways to read it. The lens re-ranks every panel, chart and row below.
Every chart is drawn from the rows currently selected and carries its value as visible text, so nothing is locked behind a hover. A chart that is also a control, entity type or state, shows the full slice for its own dimension rather than collapsing to the one bar you just clicked. Click any bar to filter the table.
Every filter applies to every view above and below it. No row cap: the pager reaches the last matching entity and the footer states the true count.
| 340B ID | Covered entity | City | ST | County | Type | Active CPs | Sites | CP / site | In 340B | Build score | Exempt score | Verdict |
|---|
Every filter, every field definition, every scoring weight and every chain-classification rule, printed in full so a 340B expert can audit the arithmetic instead of trusting it.